Botanical species · safety record

Pongamia pinnata

The EFSA Compendium of Botanicals holds 9 constituent measurements and 2 adverse-effect records for Pongamia pinnata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pongamia pinnata (L.) Pierre

9Constituent measurements

2Safety records

8Cited sources

0Licensed products (Canada)

Also recorded as

Millettia pinnata (L.) Panigrahi
Pongamia glabra Vent.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Stem / stalk	Solvent extraction	—	Phytochemical screening	Resolve DOI
Erucic acid	Seed	Solvent extraction	15.9 Percent	Unspecified	Resolve DOI
Phytic acid	Seed	Solvent extraction	0.65 Percent	Phytochemical screening	Resolve DOI
Tannins	Stem / stalk	Solvent extraction	—	Phytochemical screening	Resolve DOI
Evonine	Unspecified	Solvent extraction	—	GC-MS	No resolvable identifier
Isoflavones	Unspecified	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Karanjin	Seed	Solvent extraction	0.19 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Karanjin	Seed	Solvent extraction	1.25 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Pongamol	Seed	Solvent extraction	0.85 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Seed	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Seed	—	—	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Badole, Sachin L., Subhash., Bodhankar, L. Antihyperglycemic Activity of Pongamia pinnata Stem Bark in Diabetic Mice. PHARMACEUTICAL BIOLOGY, 2008, vol. 46, no. 12, p. 900-905. DOI
Grover, M. R. The presence and detection of some toxic components in common oils and fats. Indian food industry, 1985, p. 103-105.
Vinay, B. J., Kanya, T. C. Sindhu. Effect of detoxification on the functional and nutritional quality of proteins of karanja seed meal. FOOD CHEMISTRY, 2008, vol. 106, no. 1, p. 77-84. DOI
Bose, Madhura., Chakraborty, Mousumi., Bhattacharya, Sourav., Bhattacharjee, Pushpak., Mandal, Suvra., Kar, Manoj., Mishra, Roshnara. Suppression of NF-kappa B p65 nuclear translocation and tumor necrosis factor-alpha by Pongamia pinnata seed extract in adjuvant-induced arthritis . Journal of immunotoxicology, 2014, vol. 11, no. 3, p. 222-230. DOI
Sagwan, S., Rao, D.V., Sharma, R.A. Studies on GC/MS spectroscopic analysis of some different in vivo plant extracts of (Karanj) Pongamia pinnata (L.): Pierre. Journal of global pharma technology, 2012, vol. 4, no. 8, p. 1-10.
Li, Liya., Li, Xiang., Shi, Cui., Deng, Zhiwei., Lin, Wenhan. Studies on chemical constituents of semi-mangrove plant Pongamia pinnata. Zhongguo haiyang yaowu, 2008, p. 18-24.
Prabhu, T. M., Devakumar, C., Sastry, V. R. B., Agrawal, D. K. Quantification of karanjin using high performance liquid chromatography in raw and detoxified karanj (Pongamia glabra vent) seed cake. Asian-australasian journal of animal sciences, 2002, p. 416-420.
Panda, A. K., Sastry, V. R. B., Kumar, A., Saha, S. K. Quantification of karanjin, tannin and trypsin inhibitors in raw and detoxified expeller and solvent extracted karanj (Pongamia glabra) cake. Asian-australasian journal of animal sciences, 2006, p. 1776-1783.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature